David
Jiménez Castro
Profesor/a Titular Universidad
Medical University of Vienna
Viena, AustriaPublicacións en colaboración con investigadores/as de Medical University of Vienna (17)
2024
-
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review
Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865
-
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications
Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789
2023
-
Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment, and Outcomes From 2001 to 2020
JACC: CardioOncology, Vol. 5, Núm. 6, pp. 758-772
-
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
Clinical Research in Cardiology, Vol. 112, Núm. 10, pp. 1372-1381
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Catheter-Directed Thrombolysis vs Anticoagulation in Patients with Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial
JAMA Cardiology, Vol. 7, Núm. 12, pp. 1189-1197
-
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry
Viruses, Vol. 14, Núm. 2
2021
-
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism
European Respiratory Journal, Vol. 58, Núm. 1
-
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial
The Lancet Haematology, Vol. 8, Núm. 9, pp. e627-e636
2020
-
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)
European Heart Journal, Vol. 41, Núm. 4, pp. 543-603
-
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries
European Journal of Internal Medicine, Vol. 82, pp. 48-55
-
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months
Thrombosis Research, Vol. 196, pp. 297-304
2019
-
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
European Respiratory Journal, Vol. 54, Núm. 3
2018
-
Correction: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study [Thrombosis Journal, 16, (2018) (9)] DOI: 10.1186/s12959-018-0163-7
Thrombosis Journal
-
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
Thrombosis Journal, Vol. 16, Núm. 1
2017
-
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study
Thrombosis and Haemostasis, Vol. 117, Núm. 12, pp. 2425-2434
2015
-
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry
Thrombosis Journal, Vol. 13, Núm. 1